Protalix BioTherapeutics, Inc. - stock earnings
PLX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | - / -0.0200000000 | - | - / 9.2 million | - |
PLX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.0 million USD | 10.5 million USD |
| 2023Q3 | -1.9 million USD | 10.3 million USD |
| 2023Q2 | 19.3 million USD | 35.1 million USD |
| 2023Q1 | -3.1 million USD | 9.6 million USD |
| 2022Q4 | -3.7 million USD | 8.6 million USD |
| 2022Q3 | -4.0 million USD | 14.2 million USD |
| 2022Q2 | -5.1 million USD | 8.8 million USD |
| 2022Q1 | -2.7 million USD | 16.1 million USD |
| 2021Q4 | -6.7 million USD | 8.5 million USD |
| 2021Q3 | -4.2 million USD | 12.1 million USD |
| 2021Q2 | -11.2 million USD | 6.4 million USD |
| 2021Q1 | -5.5 million USD | 11.3 million USD |
| 2020Q4 | 397000 USD | 19.5 million USD |
| 2020Q3 | -4.4 million USD | 10.8 million USD |
| 2020Q2 | -4.2 million USD | 11.0 million USD |
| 2020Q1 | 1.7 million USD | 21.6 million USD |
| 2019Q4 | 291000 USD | 17.8 million USD |
| 2019Q3 | -3.6 million USD | 14.2 million USD |
| 2019Q2 | -7.7 million USD | 12.2 million USD |
| 2019Q1 | -7.3 million USD | 10.4 million USD |
| 2018Q4 | 9.8 million USD | 27.0 million USD |
| 2018Q3 | -15.5 million USD | 663000 USD |
| 2018Q2 | -11.3 million USD | 2.0 million USD |
| 2018Q1 | -9.4 million USD | 4.6 million USD |
| 2017Q4 | -15.1 million USD | 2.5 million USD |
| 2017Q3 | -11.4 million USD | 7.5 million USD |
| 2017Q2 | 450000 USD | 6.4 million USD |
| 2017Q1 | -59.1 million USD | 2.9 million USD |
| 2016Q4 | -2.6 million USD | 2.1 million USD |
| 2016Q3 | -7.3 million USD | 4.7 million USD |
| 2016Q2 | -10.9 million USD | 1.8 million USD |
| 2016Q1 | -8.6 million USD | 679000 USD |
| 2015Q4 | 72.9 million USD | -11.2 million USD |
| 2015Q3 | -3.8 million USD | 5.8 million USD |
| 2015Q2 | -5.1 million USD | 4.6 million USD |
| 2015Q1 | -6.0 million USD | 5.1 million USD |
| 2014Q4 | -8.5 million USD | 1.4 million USD |
| 2014Q3 | -8.0 million USD | 3.7 million USD |
| 2014Q2 | -6.1 million USD | 2.7 million USD |
| 2014Q1 | -7.3 million USD | 7.4 million USD |
| 2013Q4 | -10.9 million USD | 1.1 million USD |
| 2013Q3 | -5.7 million USD | 3.4 million USD |
| 2013Q2 | -6.8 million USD | 3.1 million USD |
| 2013Q1 | -4.3 million USD | 4.0 million USD |
| 2012Q4 | -9.9 million USD | 48000 USD |
| 2012Q3 | -5.5 million USD | 5.4 million USD |
| 2012Q2 | 9.6 million USD | 26.1 million USD |
| 2012Q1 | -5.9 million USD | 3.7 million USD |
| 2011Q4 | -8.9 million USD | 2.4 million USD |
| 2011Q3 | -8.9 million USD | 1.1 million USD |
| 2011Q2 | -13.7 million USD | 764000 USD |
| 2011Q1 | -5.1 million USD | 6.0 million USD |
| 2010Q4 | -8.5 million USD | 1.2 million USD |
| 2010Q3 | -2.5 million USD | 3.2 million USD |
| 2010Q2 | -10.0 million USD | 1.1 million USD |
| 2010Q1 | -8.0 million USD | 1.1 million USD |
| 2009Q4 | -14.9 million USD | 388000 USD |
| 2009Q3 | -5.9 million USD | ? USD |
| 2009Q2 | -5.4 million USD | ? USD |
| 2009Q1 | -5.2 million USD | ? USD |
| 2008Q4 | -6.6 million USD | ? USD |
| 2008Q3 | -6.5 million USD | ? USD |
| 2008Q2 | -4.2 million USD | ? USD |
| 2008Q1 | -5.1 million USD | ? USD |
| 2007Q4 | -5.1 million USD | ? USD |
| 2007Q3 | -4.7 million USD | ? USD |
| 2007Q2 | -12.6 million USD | ? USD |
| 2007Q1 | -3.5 million USD | ? USD |
| 2006Q4 | -9.3 million USD | 150000 USD |
| 2006Q3 | -106707 USD | ? USD |
| 2006Q2 | 28898 USD | ? USD |
| 2006Q1 | -11247 USD | ? USD |
| 2005Q4 | -19850 USD | ? USD |
| 2005Q3 | -31946 USD | ? USD |
| 2005Q2 | -12776 USD | ? USD |
| 2005Q1 | -10358 USD | ? USD |
| 2004Q4 | -31544 USD | ? USD |
| 2004Q3 | -43290 USD | ? USD |
| 2004Q2 | -58543 USD | ? USD |
| 2004Q1 | -26693 USD | ? USD |
| 2003Q4 | -46187 USD | ? USD |
| 2003Q3 | -32256 USD | ? USD |
| 2003Q2 | -29784 USD | ? USD |
| 2003Q1 | -32487 USD | ? USD |
| 2002Q4 | -49670 USD | ? USD |
| 2002Q3 | -32158 USD | ? USD |
| 2002Q2 | -32176 USD | ? USD |
| 2002Q1 | -35758 USD | ? USD |
| 2001Q4 | -56060 USD | ? USD |
| 2001Q3 | -48325 USD | ? USD |
| 2001Q2 | -52524 USD | 1 USD |
| 2001Q1 | -64599 USD | 1 USD |
| 2000Q4 | -64599 USD | ? USD |
| 2000Q3 | 12425 USD | 1 USD |
| 2000Q2 | -12049 USD | 1 USD |
| 2000Q1 | -41386 USD | 1 USD |
| 1999Q4 | -377287 USD | 43386 USD |
| 1999Q3 | -210953 USD | 166750 USD |
| 1999Q2 | -37567 USD | 1.2 million USD |
| 1999Q1 | -372059 USD | 2.2 million USD |
| 1998Q4 | -890000 USD | 2.8 million USD |
| 1998Q3 | -10000 USD | 2.9 million USD |
| 1998Q2 | -50000 USD | 2.3 million USD |
| 1998Q1 | -200000 USD | ? USD |
| 1997Q4 | -190000 USD | ? USD |
| 1997Q3 | -200000 USD | ? USD |
| 1997Q2 | -140000 USD | ? USD |
| 1997Q1 | -100000 USD | ? USD |
| 1996Q4 | 80000 USD | ? USD |
| 1996Q3 | 30000 USD | ? USD |
PLX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 8.3 million USD | 65.5 million USD |
| 2022 | -14.9 million USD | 47.6 million USD |
| 2021 | -34.0 million USD | 38.4 million USD |
| 2020 | -14.9 million USD | 62.9 million USD |
| 2019 | -26.2 million USD | 54.7 million USD |
| 2018 | -26.5 million USD | 34.2 million USD |
| 2017 | -85.3 million USD | 19.2 million USD |
| 2016 | -29.4 million USD | 9.2 million USD |
| 2015 | 58.0 million USD | 4.4 million USD |
| 2014 | -29.9 million USD | 15.2 million USD |
| 2013 | -27.8 million USD | 11.5 million USD |
| 2012 | -11.6 million USD | 34.4 million USD |
| 2011 | -36.5 million USD | 8.4 million USD |
| 2010 | -29.0 million USD | 6.6 million USD |
| 2009 | -31.4 million USD | 388000 USD |
| 2008 | -22.4 million USD | ? USD |
| 2007 | -22.5 million USD | ? USD |
| 2006 | -9.4 million USD | 150000 USD |
| 2005 | -74931 USD | ? USD |
| 2004 | -160070 USD | ? USD |
| 2003 | -140714 USD | ? USD |
| 2002 | -149762 USD | ? USD |
| 2001 | -329173 USD | ? USD |
| 2000 | -105609 USD | 1 USD |
| 1999 | -997866 USD | 3.6 million USD |
| 1998 | -1.1 million USD | 8.0 million USD |
| 1997 | 118445 USD | ? USD |
| 1996 | 131681 USD | ? USD |
PLX
Price: $1.14
52 week price:
Earnings Per Share: 0.09 USD
P/E Ratio: 16.33
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 637200
Market Capitalization: 88.4 million